XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
US Stock MarketDetailed Quotes
HRTX Heron Therapeutics
- 1.780
- +0.130+7.88%
Close Feb 14 16:00 ET
- 1.770
- -0.010-0.57%
Post 19:01 ET
270.73MMarket Cap-11.13P/E (TTM)
1.810High1.640Low1.16MVolume1.650Open1.650Pre Close2.05MTurnover1.00%Turnover RatioLossP/E (Static)152.09MShares3.93052wk High-6.77P/B205.49MFloat Cap1.04052wk Low--Dividend TTM115.44MShs Float830.000Historical High--Div YieldTTM10.30%Amplitude0.500Historical Low1.771Avg Price1Lot Size
Heron Therapeutics News
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Collard Craig A
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Duarte Ira
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Forbes William P
Heron Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Rodriguez Susan
Heron Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Johnson Craig A
Heron Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Christian Waage
Heron Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Morgan Adam
Heron Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Kaseta Michael
Heron Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Dissanaike Sharmila
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Kaseta Michael
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Dissanaike Sharmila
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Johnson Craig A
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Rodriguez Susan
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Christian Waage
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Morgan Adam
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Duarte Ira
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Forbes William P
Heron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Collard Craig A
Heron Therapeutics | 8-K: Current report
Heron Therapeutics | 8-K: Current report
Trending Stocks
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum
Moo Earnings
Jan 24 10:26
TSLA earnings preview: Grab rewards by guessing the opening price!